Cargando…
Bi-HPDO3A as a novel contrast agent for X-ray computed tomography
A new bismuth-based CT agent was synthesized through a facile synthesis strategy. The in vitro stability, toxicity and CT performance were evaluated. The in vivo imaging performance was investigated using three different doses (0.5, 1.2 and 5 mmol/kg) and the result obtained at 1.2 mmol/kg was compa...
Autores principales: | Rizzo, Rebecca, Capozza, Martina, Carrera, Carla, Terreno, Enzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556142/ https://www.ncbi.nlm.nih.gov/pubmed/37798332 http://dx.doi.org/10.1038/s41598-023-43031-y |
Ejemplares similares
-
MRI Contrast Agents for Pharmacological Research
por: Terreno, Enzo, et al.
Publicado: (2015) -
Bismuth chelate as a contrast agent for X-ray computed tomography
por: Fu, Ji-jun, et al.
Publicado: (2020) -
Optimal Contrast Agent Staining of Ligaments and Tendons for X-Ray Computed Tomography
por: Balint, Richard, et al.
Publicado: (2016) -
The interaction between iodinated X‐ray contrast agents and macrocyclic GBCAs provides a signal enhancement in T(1)‐weighted MR images: Insights into the renal excretion pathways of Gd‐HPDO3A and iodixanol in healthy mice
por: Di Gregorio, Enza, et al.
Publicado: (2022) -
Heavy Metal-Based Nanoparticles as High-Performance X-ray Computed Tomography Contrast Agents
por: Ahmad, Mohammad Yaseen, et al.
Publicado: (2023)